They joined Lyonbiopole !
Creation : 08/02/2021
Employees : 3
Place : Fontanil Cornillon
Activity (biotech/medtech/healthtech) : Medtech
Who ?
VERSEVRAGE is a startup dedicated to a topical subject of major public health interest in France and internationally, smoking cessation.
We are developing an innovative treatment through our NICØDIØL solution. It is the association of an electronic drug delivery system (EDDS) by vaporization, considered as a medical device, with patented liquid formulations combining nicotine and cannabidiol (CBD) considered as the medicine. The objective is to become the first electronic tobacco and nicotine substitute in the world to obtain marketing authorization and to be considered like other nicotine replacement treatments (patch, gum).
This project represents an enrichment of the therapeutic arsenal around smoking cessation and more broadly a new road of drug administration in the future.
Why joined us ?
Lyonbiopôle is an internationally recognized competitiveness cluster in the health sector with which our structure will be able to benefit from its aura throughout the development of the project. The pooling of information and experiences of different members on various themes will allow us to capitalize on these dynamic exchanges which will be an enrichment beyond the time saved generated.
Support from the association’s various supervisory teams on the advice/support part is envisaged, particularly concerning the innovation axis linked to our project as well as the associated aid and financing strategies.
Finally, we hope to be able to reciprocate with all the connections that will be established on all the questions raised to which we could have added value.
Sébastien OMBÉ, Co-foudner & CEO
